Redmile Group, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Zymeworks Inc. Common Stock, par value $0.00001 per share (ZYME)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Zymeworks Inc. Common Stock, par value $0.00001 per share
Symbol
ZYME
Shares outstanding
69,149,471 shares
Disclosed Ownership
4,840,463 shares
Ownership
7%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 20:04:01 UTC
Date of event
31 Dec 2024
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 7% 4,840,463 0 4,840,463 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 7% 4,840,463 0 4,840,463 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 5% 3,470,727 0 3,470,727 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.